Silo Pharma (SILO) Return on Capital Employed (2018 - 2026)
Silo Pharma (SILO) posted Return on Capital Employed of 72.37% for Q1 2026, down 7.26% sequentially from 67.47% in Q4 2025, and up 1757.0% YoY from 3.9% in Q1 2025.
Silo Pharma (SILO) Return on Capital Employed (2018 - 2026) Analysis & Trends
Silo Pharma has reported Return on Capital Employed for 9 years, with the latest figure at 72.37% in Q1 2026.
- Quarterly Return on Capital Employed rose 1757.0% year-over-year to 72.37% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 72.37% (up 1757.0% YoY) and the FY2025 annual result came in at 62.42%, up 1703.0% from the prior year.
- Return on Capital Employed retreated to 72.37% in Q1 2026 per SILO's latest filing, from 67.47% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 24.16% in Q1 2022 and troughed at 98.85% in Q2 2025.
- A 5-year average of 56.77% and a median of 55.89% in 2024 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2022 and 2025: Return on Capital Employed surged 7301 bps in 2022, then sank 3691 bps in 2025.
- Over 5 years, Return on Capital Employed stood at 30.46% in 2022, then plunged by 67 bps to 50.79% in 2023, then tumbled by 46 bps to 74.3% in 2024, then increased by 9 bps to 67.47% in 2025, then slipped by 7 bps to 72.37% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 72.37%, 67.47%, and 91.35% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 20.76% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.74% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -38.20% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.68% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 26.09% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -6.85% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -50.93% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 7.88% |
| 10 | Silo Pharma | 2.92 Mn | 2.92 Mn | - | -82.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -82.33% |
| Mar 31, 2026 | -72.37% |
| Dec 31, 2025 | -67.47% |
| Sep 30, 2025 | -91.35% |
| Jun 30, 2025 | -98.85% |
| Mar 31, 2025 | -89.94% |
| Dec 31, 2024 | -74.30% |
| Sep 30, 2024 | -55.89% |
| Jun 30, 2024 | -61.93% |
| Mar 31, 2024 | -60.77% |
| Dec 31, 2023 | -50.79% |
| Sep 30, 2023 | -48.66% |
| Jun 30, 2023 | -47.55% |
| Mar 31, 2023 | -36.83% |
| Dec 31, 2022 | -30.46% |
| Sep 30, 2022 | -27.14% |
| Jun 30, 2022 | -26.65% |
| Mar 31, 2022 | -24.16% |
| Dec 31, 2021 | -26.26% |
| Sep 30, 2021 | -30.25% |